Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY.
Am J Med. 2018 Mar;131(3):260-268.e1. doi: 10.1016/j.amjmed.2017.09.047. Epub 2017 Oct 13.
Prior analyses have largely shown a survival advantage with admission to a teaching hospital for acute myocardial infarction. However, most prior studies report data on patients hospitalized over a decade ago. It is important to re-examine the association of hospital teaching status with outcomes of acute myocardial infarction in the current era.
We queried the 2010 to 2014 National Inpatient Sample databases to identify all patients aged ≥18 years hospitalized with the principal diagnosis of ST-segment elevation myocardial infarction (STEMI). Multivariable logistic regression models were constructed to compare rates of reperfusion and in-hospital outcomes between patients admitted to teaching vs nonteaching hospitals.
Of 546,252 patients with STEMI, 273,990 (50.1%) were admitted to teaching hospitals. Compared with patients admitted to nonteaching hospitals, those at teaching hospitals were more likely to receive reperfusion therapy during the hospitalization (86.7% vs 81.5%; adjusted odds ratio [OR] 1.41; 95% confidence interval [CI], 1.39-1.44; P < .001) and had lower risk-adjusted in-hospital mortality (4.9% vs 6.9%; adjusted OR 0.84; 95% CI, 0.82-0.86; P < .001). After further adjustment for differences in use of in-hospital reperfusion therapy, the association of teaching hospital status with lower risk-adjusted in-hospital mortality was significantly attenuated but remained statistically significant (adjusted OR 0.97; 95% CI, 0.94-0.99; P = .02).
Patients admitted to teaching hospitals are more likely to receive reperfusion and have lower risk-adjusted in-hospital mortality after STEMI compared with those admitted to nonteaching hospitals. Our results suggest that hospital performance for STEMI continues to be better at teaching hospitals in the contemporary era.
先前的分析表明,急性心肌梗死患者入院接受教学医院治疗具有生存优势。然而,大多数先前的研究报告的数据都是关于十多年前住院的患者。因此,重新审视教学医院的状况与当今时代急性心肌梗死患者结局的关联是非常重要的。
我们查询了 2010 年至 2014 年国家住院患者样本数据库,以确定所有年龄≥18 岁的主要诊断为 ST 段抬高型心肌梗死(STEMI)的住院患者。使用多变量逻辑回归模型比较了在教学医院和非教学医院住院的患者接受再灌注治疗和住院结局的发生率。
在 546252 例 STEMI 患者中,有 273990 例(50.1%)被收入教学医院。与收入非教学医院的患者相比,收入教学医院的患者在住院期间更有可能接受再灌注治疗(86.7% 比 81.5%;调整后的优势比 [OR] 1.41;95%置信区间 [CI],1.39-1.44;P<0.001),且风险调整后的住院死亡率较低(4.9%比 6.9%;调整后的 OR 0.84;95%CI,0.82-0.86;P<0.001)。在进一步调整住院期间再灌注治疗的使用差异后,教学医院状况与较低风险调整的住院死亡率之间的关联明显减弱,但仍具有统计学意义(调整后的 OR 0.97;95%CI,0.94-0.99;P=0.02)。
与收入非教学医院的患者相比,收入教学医院的 STEMI 患者更有可能接受再灌注治疗,且风险调整后的住院死亡率较低。我们的研究结果表明,在当代,教学医院在 STEMI 方面的表现仍然更好。